The distribution of the veterinary medicinal product in the target animal shall be described; the possibility of plasma protein binding or passage into milk or eggs and of the accumulation of lipophilic compounds shall be considered.
Déanfar cur síos ar dháileadh an táirge íocshláinte tréidliachta sa spriocainmhí. Breithneofar an fhéidearthacht go dtarlódh ceangal plasmaphróitéine nó gluaiseacht isteach i mbainne nó in uibheacha agus carnadh comhdhúile lipifileacha.